Omnicell, Inc. OMCL
Nov 11, 2026, 10:32 AM EST
- YTD
- -21.31%
- 1 year
- -3.95%
- Market cap
- 1.64B
- Revenue (ttm)
- 1.24B
- Profit margin
- 3.59%
- EPS (ttm)
- 0.96
- Shares out
- 46.00M
- P/E ratio
- 37.10
- Forward P/E
- 17.87
- YTD return
- -21.31%
- 1-year return
- -3.95%
- Volume
- 64.45K
- Avg volume
- 596.58K
- Open
- 35.79
- Previous close
- 35.90
- Day's range
- 35.29 – 36.18
- 52-week range
- 31.75 – 55.00
- Beta
- 0.89
- Analysts
- Strong Buy
- Price target
- 57.43 (+61.1%)
- Earnings date
- Feb 4, 2027
5D -2.14 (-5.63%)
Key statistics
- Enterprise value
- 1.60B
- PEG ratio
- 15.40
- Price / sales
- 1.33
- Price / book
- 1.25
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -0.90%
- Free cash flow
- 136.29M
- Total cash
- 314.86M
- Total debt
- 200.74M
- Return on equity
- 3.52%
- Short % of float
- 8.60%
- 50-day average
- 35.02
- 200-day average
- 38.64
Analyst view
Consensus: strong buy
- Target (low)
- 50.00
- Target (mean)
- 57.43
- Target (high)
- 68.00
- Strong buy1
- Buy6
- Hold1
- Sell0
- Strong sell0
Next earnings
Feb 4, 2027
Expected Feb 4, 2027. Consensus EPS estimate 0.42125.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2027 | Dec 30, 2026 | 0.4213 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 0.4175 | 0.58 | +0.16 | +38.92% |
| Jul 30, 2026 | Jun 30, 2026 | 0.4675 | 0.94 | +0.47 | +101.07% |
| Apr 28, 2026 | Mar 31, 2026 | 0.33 | 0.55 | +0.22 | +66.67% |
| Feb 5, 2026 | Dec 31, 2025 | 0.47 | 0.40 | -0.07 | -14.89% |
| Oct 30, 2025 | Sep 30, 2025 | 0.36 | 0.51 | +0.15 | +41.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Aug 3, 2026 | Piper Sandler | reit | Overweight | Overweight |
| Jul 31, 2026 | Wells Fargo | main | Overweight | Overweight |
| Jul 31, 2026 | Keybanc | main | Overweight | Overweight |
| Apr 29, 2026 | Keybanc | main | Overweight | Overweight |
| Apr 23, 2026 | Wells Fargo | main | Overweight | Overweight |
About Omnicell, Inc.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- omnicell.com
News
Buy These 3 Stocks with Broker Rating Upgrades for Big Gains
4 Undervalued Stocks That Could Benefit from a Wall Street Rally
Why Omnicell (OMCL) is a Top Momentum Stock for the Long-Term
Contrasting Coloplast A/S (OTCMKTS:CLPBY) & Omnicell (NASDAQ:OMCL)
Why Omnicell (OMCL) Might be Well Poised for a Surge
OMCL vs. VEEV: Which Stock Should Value Investors Buy Now?
Top Robotics Stocks With Strong Potential for Long-Term Growth
Best Momentum Stocks to Buy for November 5th
Does Omnicell (OMCL) Have the Potential to Rally 40.83% as Wall Street Analysts Expect?
New Strong Buy Stocks for November 5th
Your note
Sign in to keep a note on OMCL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAUER JOANNE B | Director | Stock Award(Grant) | May 31, 2026 | 49,922 |
| ETTA NCHACHA | Chief Financial Officer | Stock Award(Grant) | Mar 6, 2025 | 132,023 |
| LIPPS RANDALL A | Chief Executive Officer | Sale | Jul 14, 2026 | 0 |
| MANLEY COREY J | Officer | Sale | May 17, 2026 | 112,783 |
| NJOKU NNAMDI | President | Sale | Aug 16, 2026 | 161,224 |
| NUTT BRIAN H | Officer | Stock Award(Grant) | Mar 31, 2026 | 23,085 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.39% | 7,539,602 | 270.67M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.85% | 3,151,350 | 113.13M | Jun 29, 2026 |
| Wellington Management Group, LLP | 5.87% | 2,700,603 | 96.95M | Jun 29, 2026 |
| Dimensional Fund Advisors LP | 5.56% | 2,558,514 | 91.85M | Sep 29, 2026 |
| State Street Corporation | 4.53% | 2,085,723 | 74.88M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.28% | 1,970,472 | 70.74M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.90% | 2,714,312 | 97.44M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.98% | 1,368,386 | 49.13M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.57% | 1,181,613 | 42.42M | Sep 29, 2026 |
| Delaware Group Equity Funds V-Nomura Small Cap Core Fund | 2.53% | 1,162,437 | 41.73M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.15% | 989,975 | 35.54M | Jun 29, 2026 |
| American Century Mutual Funds, Inc.-Small Cap Growth Fund | 1.41% | 649,081 | 23.30M | Sep 29, 2026 |
